S&P 500 7,568.92 +0.36%
Nasdaq 25,372.01 +0.83%
S&P/TSX 35,532.28 −0.75%
Apple 331.90 −1.90%
Nvidia 206.69 +2.29%
Microsoft 520.99 +2.74%
Shopify 200.19 −8.02%
Royal Bank 285.42 −0.28%
CAD/USD 0.7169 +0.24%
PRE-MKT · 05:20 ET
Market ClerkRecap
Wed Nov 4 · pre-market3 signals on Nov 3175 insider buys this week · $365.2MCIRO short report next: Nov 15The week ahead

LONA

LeonaBio, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
4.73
−0.21 −4.25%
USD · Nov 2, 06:41 p.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose LONA in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
Sermonix Pharmaceuticals, Inc. and 1 related25.1%
SCHEDULE 13D/A · filed Oct 28 · investment · EDGAR ↗

“The assignment of the remaining prefunded warrant rights to acquire 2,352,932 common shares of Issuer effects the previously disclosed distribution-in-kind to PXV II as part of the plan of distribution to the owners of Sermonix's common stock as described in the original Schedule 13D and Item 5.”

Perceptive Advisors LLC and 3 related20.0%
SCHEDULE 13D/A · filed Oct 26 · investment · EDGAR ↗

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch LONA. Know when insiders buy.
One email the day a filing lands. Free.